Cargando…

Suppression of BMP signaling by PHD2 deficiency in Pulmonary Arterial hypertension

BMP signaling deficiency is evident in the lungs of patients with pulmonary arterial hypertension. We demonstrated that PHD2 deficiency suppresses BMP signaling in the lung endothelial cells, suggesting the novel mechanisms of dysregulated BMP signaling in the development of pulmonary arterial hyper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Bin, Yi, Dan, Pan, Jiakai, Dai, Jingbo, Zhu, Maggie M., Zhao, You‐Yang, Oh, S. Paul, Fallon, Michael B., Dai, Zhiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052986/ https://www.ncbi.nlm.nih.gov/pubmed/35506101 http://dx.doi.org/10.1002/pul2.12056

Ejemplares similares

Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension
por: Liu, Bin, et al.
Publicado: (2022)

E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension
por: Yi, Dan, et al.
Publicado: (2023)

Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension
por: Yi, Dan, et al.
Publicado: (2021)

BET in Pulmonary Arterial Hypertension: Exploration of BET Inhibitors to Reverse Vascular Remodeling
por: Dai, Zhiyu, et al.
Publicado: (2019)

The Role of a Lung Vascular Endothelium Enriched Gene TMEM100
por: Pan, Jiakai, et al.
Publicado: (2023)

TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling
por: Hurst, Liam A., et al.
Publicado: (2017)

Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension
por: Gomez‐Puerto, Maria Catalina, et al.
Publicado: (2019)

BMP type II receptor as a therapeutic target in pulmonary arterial hypertension
por: Orriols, Mar, et al.
Publicado: (2017)

Postpartum pulmonary circulation in pregnant rats with monocrotaline-induced pulmonary arterial hypertension
por: Jing, He, et al.
Publicado: (2020)

Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
por: Long, Lu, et al.
Publicado: (2015)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient
por: Happé, Chris, et al.
Publicado: (2020)

Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells
por: Szulcek, Robert, et al.
Publicado: (2020)

Echocardiographic Evaluation of Initial Ambrisentan Plus Phosphodiesterase Type 5 Inhibitor on Right Ventricular Pulmonary Artery Coupling in Severe Pulmonary Arterial Hypertension Patients
por: Lan, Wei-Fang, et al.
Publicado: (2022)

Egln1(Tie2Cre) Mice Exhibit Similar Therapeutic Responses to Sildenafil, Ambrisentan, and Treprostinil as Pulmonary Arterial Hypertension (PAH) Patients, Supporting Egln1(Tie2Cre) Mice as a Useful PAH Model
por: Peng, Yi, et al.
Publicado: (2023)

Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report
por: Wang, Guoliang, et al.
Publicado: (2016)

The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension
por: Ormiston, Mark L., et al.
Publicado: (2015)

PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosis
por: Elamaa, Harri, et al.
Publicado: (2022)

Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1α signaling pathway
por: Xi, Jie, et al.
Publicado: (2023)

Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10
por: Bouvard, Claire, et al.
Publicado: (2021)

Multi-Target State Extraction for the SMC-PHD Filter
por: Si, Weijian, et al.
Publicado: (2016)

GATA6 coordinates cross-talk between BMP10 and oxidative stress axis in pulmonary arterial hypertension
por: Toyama, Tetsuo, et al.
Publicado: (2023)

Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice
por: Lakhal-Littleton, Samira, et al.
Publicado: (2019)

microRNA-214-3p Suppresses Ankylosing Spondylitis Fibroblast Osteogenesis via BMP–TGFβ Axis and BMP2
por: Ding, Lixiang, et al.
Publicado: (2021)

Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2018)

Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2021)

Characteristics of Pulmonary Vascular Remodeling in a Novel Model of Shunt-Associated Pulmonary Arterial Hypertension
por: Zhang, Mingjie, et al.
Publicado: (2018)

Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
por: Joshi, Sachindra R., et al.
Publicado: (2022)

Management of Pulmonary Arterial Hypertension
por: Mayeux, Jennalyn D., et al.
Publicado: (2020)

Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy
por: Dai, Lingling, et al.
Publicado: (2022)

New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension
por: Kurdyukov, Sergey, et al.
Publicado: (2018)

“Idiopathic” pulmonary arterial hypertension in early infancy: Excluding NFU1 deficiency
por: Stéphanie, Paquay, et al.
Publicado: (2019)

Deletion of Phd2 in Myeloid Lineage Attenuates Hypertensive Cardiovascular Remodeling
por: Ikeda, Jiro, et al.
Publicado: (2013)

Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline
por: Qin, Tianyou, et al.
Publicado: (2022)

Mitochondrial dysfunction in pulmonary arterial hypertension
por: Zhang, Weiwei, et al.
Publicado: (2022)

Phd project
por: Marinho Valavicius, Priscilla
Publicado: (2020)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

H(2)S attenuates endoplasmic reticulum stress in hypoxia-induced pulmonary artery hypertension
por: Wu, Jianjun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8lm0f0evmfkj5nl0tph8of0276